Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment
Clinical trial NCT06766266 · RECRUITING
Trial details
- NCT number
- NCT06766266
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-10
- Primary completion
- 2025-04-24
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.